Advertisement

Topics

ANDA Amendments Cannot Get Mid-Review Communications Like Full Applications - FDA

14:24 EDT 13 Jun 2018 | SCRIP

Generic industry officials ask that information requests and discipline review letters be issued during ANDA amendment assessments, but the US...

      

Related Stories

 

Original Article: ANDA Amendments Cannot Get Mid-Review Communications Like Full Applications - FDA

NEXT ARTICLE

More From BioPortfolio on "ANDA Amendments Cannot Get Mid-Review Communications Like Full Applications - FDA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...